Notizie su H. Lundbeck

Ultime notizie

Titoli nella lingua originale della fonte.

• Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports (si apre in una nuova scheda)

  Investing.com · 29 set 2026

• 
  Can H. Lundbeck (CPSE:HLUN B) Look Cheap On Japan Eptinezumab Approval? (si apre in una nuova scheda)

  Simply Wall St. · 28 set 2026

• H. Lundbeck AS (HLUBF) (Q2 2026) Earnings Call Highlights: Strategic Brands Drive 16% Revenue ... (si apre in una nuova scheda)

  GuruFocus.com · 19 ago 2026

• H. Lundbeck AS (HLUBF) Full Year 2025 Earnings Call Highlights: Record Growth and Strategic Advances (si apre in una nuova scheda)

  GuruFocus.com · 4 feb 2026

• 
  Avadel (AVDL) Gets 26% Boost on Takeover Bid (si apre in una nuova scheda)

  Insider Monkey · 16 nov 2025

• 
  Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War (si apre in una nuova scheda)

  Insider Monkey · 15 nov 2025

• 
  H. Lundbeck AS (HLUBF) Q3 2025 Earnings Call Highlights: Robust Growth and Strategic Advancements (si apre in una nuova scheda)

  GuruFocus.com · 12 nov 2025